Quantitative Systematic Strategies’s Salix Pharmaceuticals SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Quantitative Systematic Strategies's SLXP Position: Q4 2014 in Review
Quantitative Systematic Strategies sold out of Salix Pharmaceuticals (SLXP) in Q4 2014, closing a stake of 14,266 shares — an estimated $2.22M sold.
Quantitative Systematic Strategies first reported a position in SLXP in Q2 2014 and held it in 2 quarters. The position peaked at $2.22M in Q3 2014. 347 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.
- Quantitative Systematic Strategies reported no remaining Salix Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
- Quantitative Systematic Strategies sold 14,266 Salix Pharmaceuticals shares in Q4 2014, an estimated $2.22M.
- Quantitative Systematic Strategies first reported a position in Salix Pharmaceuticals in Q2 2014 and held it in 2 quarters.
- Quantitative Systematic Strategies's Salix Pharmaceuticals position peaked at $2.22M in Q3 2014.
- 347 funds tracked by Wall St. Rank held Salix Pharmaceuticals as of Q4 2014.
Based on Quantitative Systematic Strategies's 13F filing for Q4 2014, filed 21 Jan 2015.